Skip to main content
  • IGH Director Kathleen Neuzil, MD, Discusses This Year’s Influenza Season

    UMSOM Expert Discusses Advances in Influenza Vaccine Research and Development

    Learn More
  • CVD Helps Bring Vaccine One Step Closer to Reaching Millions at Risk of Typhoid

    LEARN MORE
  • High-Dose Cholera Vaccine Developed by UMSOM Scientists Shows Promise for Controlling Outbreaks

    Single-dose vaccine could provide faster protection in cholera epidemics

    LEARN MORE
  • Zika Vaccine on the Horizon Thanks in Part to Work by Our IGH Researchers

    Gene-based Zika vaccine is safe and immunogenic in healthy adults

    Learn More
  • Challenges and Solutions for Primary Health Care in Low Resource Settings.

    Kenneth Leonard, PhD, Associate Professor, Agricultural and Resource Economics, University of Maryland College Park, Discusses Primary Care Evidence and Challenges in Low Resource Settings

    Learn More
  • Millions of Children Set to be Protected Against Typhoid

    Gavi Board approves US$ 85 million funding window for 2019-2020 to support the introduction of typhoid conjugate vaccine in developing countries

    LEARN MORE
  • University of Maryland School of Medicine Researchers Studying New Approach to Fighting Antibiotic-resistant Wound Infections

    U.S. military-funded research could help stave off drug-resistant staph infections

    Learn More

Center for Vaccine Development (CVD)

Preventing disease and saving lives through development and delivery of vaccines

For over 40 years, the CVD at the University of Maryland School of Medicine (UM SOM) in Baltimore, MD has worked domestically and internationally to develop, test, and deploy vaccines to aid the world’s underserved populations.

The CVD is an academic enterprise engaged in the full range of vaccinology from basic laboratory research through vaccine development, pre-clinical and clinical evaluation, large-scale pre-licensure field studies, and post-licensure assessments.


News

Click on the "News" link above to read more about CVD in the news.

Hot off the Press

Kathleen Neuzil, MD, MPH featured in Uncovering Advantages of the New Typhoid Vaccine, 4 January 2018.

Kathleen Neuzil, MD, MPH on Influenza: The Master of Mutation, 4 January 2018.

 

More Stories


‌‌‌Learn More


Follow Us


Give to the CVD

Volunteer Opportunities